Telehealth Behavioral Activation Program for Teens Aged 12 to 18 with Depression or Suicidal Thoughts
Led by Baylor College of Medicine · Updated on 2026-08-04
250
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What this Trial Is About
Rates of depression and suicide among youth are rising significantly, especially in Texas where access to mental healthcare is limited. This research focuses on teens aged 12 to 18 experiencing depression or suicidal thoughts who are enrolled in the Youth Depression Suicide Network study. Behavioral activation, derived from cognitive-behavioral therapy, is an evidence-based approach that encourages engagement in valued activities to improve depressive symptoms.
Participants will receive behavioral activation treatment through telehealth for 8 to 10 weeks. This intervention uses psychoeducation and skill-building to increase involvement in enjoyable activities such as socializing, exercising, or hobbies. The program can be delivered by trained clinicians or non-licensed interventionists in a brief, virtual format.
Throughout the study, participants will complete weekly sessions and assessments including the Patient Health Questionnaire modified for adolescents, Behavioral Activation for Depression-Short Form, and Dimensional Anhedonia Rating Scale. Additional questionnaires such as the Strengths and Difficulties Questionnaire and Duke Social Support Index will be completed at the start and end of treatment. The study tracks symptom changes and social support during treatment lasting approximately 10 weeks.
CONDITIONS
Brief Title
Telehealth Behavioral Activation for Teens
Research Team
E
Emily Bivins, B.S.
E
Eric Storch, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Tele‑BA (study)
CBT (guideline‑recommended)
what it is
A structured telehealth behavioral activation programme delivered weekly over 8 to 10 weeks to adolescents with depressive symptoms
An evidence‑based psychotherapy that focuses on changing thoughts and behaviors to reduce depression symptoms
role in study
This is the single experimental intervention delivered to all participants
This represents standard psychotherapy typically offered outside the study, not assigned as a trial arm
primary use
To reduce depressive symptoms in adolescents via structured activity and engagement
To treat adolescent depression by modifying unhelpful thoughts and behaviors
how it is delivered
Delivered remotely via telehealth in weekly sessions over approximately eight to ten weeks
Typically delivered in‑person or via telehealth in weekly sessions, varying by provider
evidence maturity
Effectiveness still being evaluated; results not yet available
Well‑established efficacy in adolescent depression treatment
important risks
None specifically reported; standard risks of therapy apply
Minimal risks related to psychotherapy, such as emotional discomfort during sessions
limitations
Single‑group design without a control arm limits comparisons to standard care
Variability in delivery and access across settings may affect consistency
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 12Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Must be enrolled in the Texas Youth Depression Suicide Research Network Registry Study
Be between 12 and 18 years old or currently enrolled in high school
Have a caregiver willing to participate in the program
Able to commit to weekly sessions for eight weeks
Currently experiencing depressive symptoms
Able to participate in telehealth services within Texas
Willing to provide consent or assent
Able to read, write, and speak English or Spanish to understand study procedures
Willing to complete scheduled assessments and attend sessions
Able to provide a reliable way to be contacted
You will not qualify if you...
Have an acute medical or psychological condition that makes participation difficult or unsafe
Have a condition that prevents accurate completion of study requirements (e.g., neurological or neurodevelopmental concerns)
Have active psychotic or manic symptoms that alter mental status or require urgent care
Have a caregiver who is unable to provide consent due to cognitive issues
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (virtual or in-person)
Treatment
Duration - 8 to 10 weeks
Participants receive weekly telehealth behavioral activation sessions aimed at increasing engagement in enjoyable activities to improve depressive symptoms.
Weekly sessions
Follow-up
Duration - 1 week
Participants complete final assessments to measure changes in depression symptoms and social support after treatment.
1 session
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Study of How a Single Dose of Citalopram Affects Brain Response to Emotional Faces Using 7T fMRI in Adults Aged 18 to 40
Imaging PDE4B Levels in Adults with Major Depressive Disorder Using PET Scans with 18FPF-06445974
Remote Community Health Worker-Delivered Counseling via mHealth to Reduce Anxiety and Depression in Adults With HIV
Evaluating Deprexis, an Online Program to Reduce Depression and Improve Functioning in Veterans
Digital Treatment Using iPad-Based Training and Coaching to Improve Depression and Cognitive Problems After Stroke in Adults Aged 50 to 79
Ketamine-Assisted Group Therapy for Spanish-Speaking Adults with Depression, Phase 1-2 Pilot Study
Study of One Oral Dose of CYB003 to Explore Effects on Brain Activity in Adults With Major Depressive Disorder and Moderate to Severe Anxiety
Comparing Connectome-guided and Anatomically-guided Accelerated Intermittent Theta Burst Stimulation for Treating Depression A Double-Blind Randomized Trial
Testing Personalized vs Standardized Emotion Regulation Skills
for Improving Emotional Health and Reducing Negative Feelings
Psychosocial Therapy to Improve Memory, Depression, and Pain in Older Adults with Mild Cognitive Impairment or Early Alzheimers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Two Trajectories of Depressive Symptom Reduction Throughout Behavioral Activation Teletherapy Among Underserved, Ethnically Diverse, Primary Care Patients: A VitalSign6 Report.
Joseph M Trombello, Charles South, Alma Sánchez...